Barclays’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-39
| Closed | – | – | 6709 |
|
|
2019
Q4 | $0 | Sell |
39
-1,088
| -97% | -$3.46K | ﹤0.01% | 7115 |
|
|
2019
Q3 | $3K | Buy |
+1,127
| New | +$3.17K | ﹤0.01% | 6529 |
|
|
2019
Q2 | – | Sell |
-1,124
| Closed | -$4K | – | 7505 |
|
|
2019
Q1 | $4K | Buy |
1,124
+407
| +57% | +$1.52K | ﹤0.01% | 6780 |
|
|
2018
Q4 | $3K | Sell |
717
-6,749
| -90% | -$29.4K | ﹤0.01% | 6669 |
|
|
2018
Q3 | $43K | Sell |
7,466
-13,180
| -64% | -$75.4K | ﹤0.01% | 6168 |
|
|
2018
Q2 | $104K | Sell |
20,646
-96,750
| -82% | -$498K | ﹤0.01% | 5219 |
|
|
2018
Q1 | $602K | Buy |
117,396
+110,801
| +1,680% | +$667K | ﹤0.01% | 3773 |
|
|
2017
Q4 | $40K | Buy |
+6,595
| New | +$39.7K | ﹤0.01% | 5887 |
|
|
2017
Q3 | – | Sell |
-149
| Closed | -$1K | – | 7172 |
|
|
2017
Q2 | $1K | Hold |
149
| – | – | ﹤0.01% | 6568 |
|
|
2017
Q1 | $1K | Sell |
149
-1,107
| -88% | -$10.7K | ﹤0.01% | 6691 |
|
|
2016
Q4 | $14K | Sell |
1,256
-261,280
| -100% | -$2.46M | ﹤0.01% | 5793 |
|
|
2016
Q3 | $2.43M | Buy |
262,536
+259,741
| +9,293% | +$2.17M | ﹤0.01% | 1837 |
|
|
2016
Q2 | $17K | Sell |
2,795
-663
| -19% | -$4.4K | ﹤0.01% | 5345 |
|
|
2016
Q1 | $21K | Buy |
3,458
+2,921
| +544% | +$18.8K | ﹤0.01% | 5205 |
|
|
2015
Q4 | $4K | Buy |
537
+419
| +355% | +$3.13K | ﹤0.01% | 5642 |
|
|
2015
Q3 | $1K | Sell |
118
-6,015
| -98% | -$61.3K | ﹤0.01% | 6683 |
|
|
2015
Q2 | $61K | Buy |
+6,133
| New | +$67.8K | ﹤0.01% | 5025 |
|
|
2014
Q4 | – | Sell |
-5,700
| Closed | -$29K | – | 7746 |
|
|
2014
Q3 | $29K | Buy |
+5,700
| New | +$32.7K | ﹤0.01% | 6254 |
|
Barclays's FOMX Position: Q1 2020 in Review
Barclays sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 39 shares.
Barclays first reported a position in FOMX in Q3 2014 and held it in 18 quarters. The position peaked at $2.43M in Q3 2016. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.
- Barclays reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
- Barclays sold 39 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020.
- Barclays first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2014 and held it in 18 quarters.
- Barclays's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $2.43M in Q3 2016.
- 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.
Based on Barclays's 13F filing for Q1 2020, filed 13 May 2020.